Immune response of a two-dose heterologous Ebola vaccine regimen: summary of three African clinical trials using a single validated Filovirus Animal Nonclinical Group enzyme-linked immunosorbent assay in a single accredited laboratory

Autor: McLean, Chelsea, Barry, Houreratou, Kieh, Mark, Anywaine, Zacchaeus, Tapima Rogers, Baimba, Doumbia, Seydou, Sirima, Sodiomon B., Serry-Bangura, Alimamy, Habib Beavogui, Abdoul, Gaddah, Auguste, Katwere, Michael, Hendriks, Jenny, Keshinro, Babajide, Eholie, Serge, Kibuuka, Hannah, Kennedy, Stephen B., Anzala, Omu, Samai, Mohamed, D'Ortenzio, Eric, Leigh, Bailah, Sow, Samba, Thiébaut, Rodolphe, Greenwood, Brian, Watson-Jones, Deborah, Douoguih, Macaya, Luhn, Kerstin, Robinson, Cynthia
Zdroj: In eBioMedicine May 2023 91
Databáze: ScienceDirect